Takeda Pharmaceuticals Ltd. and Seattle Genetics Inc. recently announced that their Adcetris drug, which was created to treat advanced Hodgkin lymphoma, met its primary endpoint during the Phase 3 Echelon-1 clinical trial. Read More »

Two third generation hepatitis B vaccine trials to enroll 4,800 participants in the U.S., Canada and Europe. Read More »

GeoVax announced promising results in testing a Lassa hemorrhagic fever vaccine (LASV) in mice. Read More »

Aridis Pharmaceuticals Inc. recently announced positive results for its Phase 2a trial of Salvecin for treating severe pneumonia caused by Staphylococcus aureus. Read More »

ESSA Pharma Inc. recently announced early data from its Phase 1 clinical trial for EPI-506, an anti-tumor drug. Read More »

Zavante Therapeutics Inc. recently announced that multiple in vitro studies provide support for Zolyd, combined with certain other antibiotics, as a bacteria killer. Read More »

Novo Nordisk recently announced positive results from its phase 3b Dual VII clinical trial for Xultophy, a product created to treat type 2 diabetes. Read More »

With the brand-new option to make “best-of-breed” choices at the pharmacy counter, existing Premier Inc. members may now take advantage of pricing solutions through a new partnership between Premier and supplier Swisslog Healthcare. Read More »

Theravance Biopharma Inc. recently presented positive data from multiple Vibativ studies at the ASM Microbe 2017 Meeting, the annual gathering of the American Society for Microbiology held in New Orleans. Read More »

Genentech recently released positive results for its Phase III ALEX study analyzing Alecensa, a drug that treats anaplastic lymphoma kinase-positive advanced non-small cell lung cancer. Read More »

Sanofi and Regeneron Pharmaceuticals recently announced positive results from two Praluent-focused Phase 3b/4 Odyssey-DM trials involving diabetes patients. Read More »

Genentech, a member of the Roche Group, along with the Breast International Group, Breast European Adjuvant Study Team and Frontier Science Foundation, recently announced positive results from the Phase III Aphinity study for Perjeta and Herceptin-based adjuvant treatment in combating breast cancer. Read More »

eFFECTOR Therapeutics recently presented Phase 1 clinical trial data for its lead product candidate, eFT508, at the 2017 American Society of Clinical Oncology annual meeting in Chicago. Read More »

McKesson Pharmacy Systems recently unveiled two new features — Medication Synchronization and Mobile Delivery — serving its pharmacy management suite, which comprises EnterpriseRx, PharmacyRx and Pharmaserv systems. Read More »

Arena Pharmaceutical Inc. has completed Phase 1 of its comparative bioavailability study on pharmacokinetic profile of extended release ralinepag in comparison to immediate release. Read More »

Pfizer Inc. and Merck released positive data from two Phase 3 studies of ertugliflozin, an investigational oral GGLT-2 inhibitor that seeks to treat Type 2 diabetes patients by improving glycemic control. Read More »

A decade-long study of GSK’s Benlysta — the longest to date — recently culminated with indications of the drug’s safety and efficacy against active systemic lupus erythematosus, when administered with standard care. Read More »

Lexicon Pharmaceuticals Inc. recently presented its two sotagliflozin studies, inTandem1 and inTandem2, at the 77th American Diabetes Association Scientific Sessions in San Diego, California. Read More »

Introducing an innovative “bi-directional integration” between two existing systems, Baxter International Inc. recently combined its DoseEdge pharmacy workflow management system with the Epic Willow Inpatient Pharmacy System. Read More »

Amgen recently presented 19 scientific abstracts at the 59th Annual Scientific Meeting of the American Headache Society, which took place in Boston. Read More »